FibroGen Inc (NASDAQ: FGEN) is 47.81% higher on its value in year-to-date trading and has touched a low of $0.33 and a high of $20.90 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The FGEN stock was last observed hovering at around $1.30 in the last trading session, with the day’s gains setting it 0.01%.
Currently trading at $1.31, the stock is -35.16% and -35.22% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.27 million and changing 0.77% at the moment leaves the stock -1.62% off its SMA200. FGEN registered -93.34% loss for a year compared to 6-month gain of 111.26%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -37.32% loss in the last 1 month and extending the period to 3 months gives it a 74.06%, and is -19.63% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.91% over the week and 15.78% over the month.
FibroGen Inc (FGEN) has around 486 employees, a market worth around $129.39M and $147.75M in sales. Profit margin for the company is -192.37%. Distance from 52-week low is 293.04% and -93.73% from its 52-week high.
The EPS is expected to grow by 55.68% this year.
FibroGen Inc (FGEN) Top Institutional Holders
The shares outstanding are 98.77M, and float is at 91.83M with Short Float at 5.65%.
FibroGen Inc (FGEN) Insider Activity
The most recent transaction is an insider purchase by Wettig Thane,the company’sCEO. SEC filings show that Wettig Thane bought 50,000 shares of the company’s common stock on Mar 07 ’24 at a price of $1.91 per share for a total of $95470.0. Following the purchase, the insider now owns 0.47 million shares.
FibroGen Inc disclosed in a document filed with the SEC on Sep 01 ’23 that Henderson Jeffrey William (Director) sold a total of 2,000 shares of the company’s common stock. The trade occurred on Sep 01 ’23 and was made at $1.03 per share for $2060.0. Following the transaction, the insider now directly holds 28866.0 shares of the FGEN stock.
Still, SEC filings show that on Aug 04 ’23, Henderson Jeffrey William (Director) disposed off 2,000 shares at an average price of $1.91 for $3820.0. The insider now directly holds 30,866 shares of FibroGen Inc (FGEN).
